FDA - Food and Drug Administration

Israeli pride: Phytolon receives FDA approval – sparks significant interest in the U.S.

Millennium FoodTech R&D Partnership: Portfolio company Phytollon, which develops natural and innovative food colorings, received FDA approval to market its first product in the U.S.

Portfolio company Phytoon, which develops natural and innovative food colorings, received FDA approval to market its first product in the U.S
(Illustrative) A doctor uses AI for a medical screening.

FDA clears AI model to triage urgent CT findings, Israeli firm says

ENDOART, A synthetic endothelial layer for the treatment of chronic corneal edema.

FDA clears first US trial of Israel’s EndoArt synthetic corneal implant

 Dividing cancer cell

Arizona couple admits in court to faking cancer-curing 'smart chip' device


COVID-19: FDA to authorize Pfizer booster vaccine for older Americans

Advisers to the FDA voted on Friday to recommend COVID-19 vaccine booster shots for Americans 65 and older.

Signage is seen outside of FDA headquarters in White Oak, Maryland.

Pfizer says vaccine safe, effective for kids 5-11, will apply for EUA

“Over the past nine months, hundreds of millions of people ages 12 and older from around the world have received our COVID-19 vaccine,” said company CEO Albert Bourla in a release.

A NURSE draws up a COVID-19 vaccine dose at a Magen David Adom vaccination center in Jerusalem earlier this month.

Was Israel’s decision to give everyone COVID boosters a shot in the dark?

Some parents are now questioning if Israel didn’t rush too fast to jab their children.

An elderly Israeli is seen receiving the third COVID-19 booster shot at a Clalit clinic in Jerusalem, on August 1, 2021.

FDA advisers vote unanimously to give COVID booster to people 65+

US health experts say not enough evidence to give third shot to younger people, as Israel boasts crossing 3 million with the booster.

 People waiting in line at an MDA station to receive their coronavirus vaccines in Tel Aviv, August 14 2021

COVID-19: Israel to present booster shot data to FDA experts

So far 2.6 million people out of a population of 9.3 million have received three doses of the Pfizer vaccine in Israel.

 Third vaccine doses being administered at the Amigdor Retirement Residence by Magen David Adom (MDA), Jerusalem, August 5, 2021.

Pfizer starts process to seek US approval of COVID-19 vaccine booster

Pfizer Inc on Wednesday began the process for full approval of its COVID-19 booster dose in the United States.

A healthcare worker hands over doses of the Pfizer-BioNTech COVID-19 vaccine to a doctor at Messe Wien Congress Center, which has been set up as coronavirus disease vaccination centre, in Vienna, Austria February 7, 2021.

Pfizer COVID vaccine finally wins full FDA approval

The vaccine will now be officially marketed under the name Comirnaty * Pfizer shares were up around 5% and BioNTech shares were up more than 9%.

Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Pfizer logo in this illustration taken October 31, 2020

COVID: Pfizer sends data on booster to FDA, as 1M Israelis already jabbed

At the moment, Israel is the only country in the world administering a booster to a vast segment of its population – all individuals over 50.

A health worker is seen preparing to administer the a third COVID-19 booster shot (illustrative).

FDA: Immuno-compromised authorized to receive COVID vaccine boosters

Pfizer: Efficacy of COVID vaccine drops over time

PFIZER AND MODERNA were able to develop their mRNA vaccines against COVID-19 so quickly because the scientific community has been experimenting with mRNA for so many years for other indications.

FDA expected to authorize COVID vaccine booster shots this week

An FDA announcement on coronavirus vaccine boosters is expected within the next 48 hours, but the timing could move.

An Israeli woman receives the coronavirus vaccine